NGeneBio Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	24,692	36,556	32,411	71,664	116,027	201,381
Market Cap Growth	-32.62%	12.79%	-54.77%	-38.23%	-42.38%	-
Enterprise Value	50,511	46,835	40,754	56,797	89,239	-
Last Close Price	921.00	1460.00	1642.00	4897.30	8173.92	14269.12
PS Ratio	0.79	1.72	5.78	16.47	10.53	28.11
PB Ratio	1.12	1.62	1.83	4.41	4.58	5.92
P/TBV Ratio	1.42	2.03	3.54	4.97	4.91	6.23
EV/Sales Ratio	1.62	2.21	7.26	13.05	8.10	-
Debt / Equity Ratio	1.48	1.47	0.51	0.71	0.45	0.21
Net Debt / Equity Ratio	1.19	1.22	0.09	-0.68	-0.93	-0.50
Net Debt / EBITDA Ratio	-4.34	-4.56	-0.16	0.91	3.20	2.22
Net Debt / FCF Ratio	-0.82	-0.80	-0.12	1.15	2.65	1.62
Asset Turnover	0.62	0.40	0.15	0.09	0.22	-
Inventory Turnover	15.54	9.99	1.89	1.93	3.29	-
Quick Ratio	0.39	0.41	0.66	0.98	1.25	3.22
Current Ratio	0.48	0.51	0.93	1.14	1.49	3.40
Return on Equity (ROE)	-29.04%	-16.64%	-64.41%	-61.88%	-33.17%	-
Return on Assets (ROA)	-9.66%	-9.83%	-20.92%	-17.05%	-10.75%	-
Return on Capital Employed (ROCE)	-33.20%	-34.00%	-61.60%	-72.70%	-31.70%	-24.40%
Earnings Yield	-28.35%	-15.16%	-40.03%	-17.82%	-8.43%	-4.19%
FCF Yield	-128.87%	-93.92%	-38.77%	-13.33%	-7.63%	-5.24%
Buyback Yield / Dilution	-51.10%	-58.58%	-11.80%	-1.66%	-0.89%	-